Survival benefit of adjuvant chemotherapy for duodenal adenocarcinoma: a retrospective cohort study and propensity score-matched analysis

This large, population-based study provides robust evidence that AC is associated with significantly improved survival after surgery for DAC, particularly in older patients and those with lymph node-positive or locally advanced disease. These findings support the use of AC to enhance survival outcomes in specific DAC patient groups.